BIOLASE Inc (NASDAQ:BIOL)

1.61
Delayed Data
As of Sep 22
 -0.13 / -7.47%
Today’s Change
1.56
Today|||52-Week Range
279.00
-97.52%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues48.1M51.8M46.9M46.2M
 
 
 
 
 
Cost of Goods Sold31.6M30.1M30.1M28.3M
 
 
 
 
 
Depreciation And Amortization880.0K1.0M1.2M945.0K
 
 
 
 
 
 
Operating ExpensesGross Income15.6M20.7M15.6M16.9M
 
 
 
 
 
General Expenses36.2M35.3M32.7M35.1M
 
 
 
 
 
Other Operating Expenses0.00348.0K492.0K0.00
 
 
 
Research And Development7.3M7.8M6.2M5.2M
 
 
 
 
 
Total Operating Expenses68.8M66.8M64.5M64.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-20.6M-15.0M-17.5M-18.2M
 
 
 
 
 
Extraordinary Credit731.0K0.000.000.00
 
 
Extraordinary Charge0.000.000.00-1.5M
 
 
Interest Expense On Debt0.00--0.00510.0K
 
 
Other Expenses-259.0K-332.0K58.0K-1.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-20.1M-15.2M-17.4M-21.5M
 
 
 
 
 
Income Taxes-178.0K-151.0K-582.0K-63.0K
 
 
 
 
 
Preferred Dividend0.00-2.2M-4.0M0.00
 
 
 
Net Income-20.3M-15.4M-16.9M-21.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS11.6M12.1M14.8M20.6M
 
 
 
 
 
Shares To Calculate EPS Diluted11.6M12.1M14.8M20.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.75-$1.45-$1.40-$1.05
 
 
 
 
 
EPS Diluted-$1.75-$1.45-$1.40-$1.05